AMMF’s Hybrid 2023 European Cholangiocarcinoma Conference

All presentations from AMMF’s 3-day European Cholangiocarcinoma Conference held 10-12 May 2023 are now available here to watch again. Simply click on the topic title to see that presentation. 

Topic Presenter
WELCOME DAY THREE
Welcome to Day 3 Professor John Bridgewater
Professor Lorenza Rimassa
CCA SPECIALIST GROUP UPDATES
ENS–CCA – Overview and update Dr Chiara Braconi
Chair – ENS-CCA
CCA-UK – Overview and update Professor Shahid A Khan
Chair – CCA-UK
Question time Panel
BIG DATA
Introduction to Session Dr Shirin Elizabeth Khorsandi
Kings College, London

Dr Tim Kendall
University of Edinburgh
Molecular data: Implications of genomics in cholangiocarcinoma Professor Jesper B Andersen
University of Copenhagen, Denmark
How can AI inform physician’s decisions? Professor Julien Calderaro
Henri Mondor University Hospital, France
Exploring Protein Kinase CK2 inhibition and identifying new targets Professor Kevin Gaston
University of Nottingham
Question time Panel
NOVEL FINDINGS IN CCA RESEARCH
The role of normal cholangiocytes in regulating cholangiocarcinoma cells during co-culture Gemma Owen
University of Oxford
KLF5 upregulation is a common event in cholangiocarcinoma, acting as an oncogene and constituting a bad prognostic factor Dr Pedro M. Rodrigues
Biodonostia Health Research Institute, Spain
A Notch signalling niche drives the initiation and early growth of cholangiocarcinoma Dr Anabel Martinez Lyons
University Of Edinburgh
Question Time Panel
Patient Perspective Francesca Clementi
TRANSLATION INTO CLINICAL PRACTICE
The ENSCCA clinical database: current status, studies and new results Professor Jesus Bañales
Biodonostia Institute, Spain
Biomarkers from the BILCAP series: Focus on HER2 Dr Valerie Crolley
University College Hospital London
Acquired resistance to FGFR inhibitors Dr Daniel DiToro
Brigham and Women’s Hospital, Boston
Question Time Panel
WORKSHOP ON PRECLINICAL MODELS
Characterisation of A Precision Cut Tumour Slice Model to Explore cholangiocarcinoma Dr Laura Randle
Liverpool John Moores University and The University of Liverpool
Novel genetically engineered mouse models of cholangiocarcinoma Professor Jen Morton
Cancer Research UK Beatson Institute
Question time Panel
Conference highlights Professor John Bridgewater
Professor Lorenza Rimassa
Back to previous page